Elesclomol is a novel, injectable, small molecule chemotherapeutic agent that has demonstrated preclinical efficacy in AML.[1,2] Mechanistically, elesclomol binds copper (Cu) in the form of Cu2+ in...
No takes yet. Share an insight, caveat, or question.
Hedley et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: